These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28506184)

  • 1. Complications of Psychotropic and Pain Medications in an Ultrarapid Metabolizer Patient at the Upper 1% of Cytochrome P450 (CYP450) Function Quantified by Combinatorial CYP450 Genotyping.
    Ruaño G; Larsen K; Kocherla M; Graydon JS; Kost J
    J Pain Palliat Care Pharmacother; 2017 Jun; 31(2):126-138. PubMed ID: 28506184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
    Naujokaitis D; Asmoniene V; Kadusevicius E
    Medicine (Baltimore); 2021 Mar; 100(11):e24545. PubMed ID: 33725937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.
    McGrane IR; Loveland JG
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):395-9. PubMed ID: 26871369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of CYP450 testing in the clinical setting.
    Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
    Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies.
    Ruaño G; Blair CL; Bower B; Windemuth A; Kocherla M; Aleman Y; Pearlson G; Goethe JW; Schwartz HI
    Conn Med; 2007 Apr; 71(4):197-200. PubMed ID: 17487003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How common are drug and gene interactions? Prevalence in a sample of 1143 patients with CYP2C9, CYP2C19 and CYP2D6 genotyping.
    Verbeurgt P; Mamiya T; Oesterheld J
    Pharmacogenomics; 2014 Apr; 15(5):655-65. PubMed ID: 24798722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.
    Manworren RC; Jeffries L; Pantaleao A; Seip R; Zempsky WT; Ruaño G
    Clin J Pain; 2016 Feb; 32(2):109-15. PubMed ID: 25803758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of CYP2C9, CYP2C19, and CYP2D6 Polymorphisms in Allergic Patients with Chemical Sensitivity.
    D'Attis S; Massari S; Mazzei F; Maio D; Vergallo I; Mauro S; Minelli M; Bozzetti MP
    Int Arch Allergy Immunol; 2019; 179(3):173-186. PubMed ID: 30943525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major CYP450 Polymorphism among Saudi Patients.
    Almeman AA
    Drug Metab Lett; 2021; 14(1):17-24. PubMed ID: 32703145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula.
    Carano F; Sarno S; De Fanti S; Serventi P; Bini C; Luiselli D; Pelotti S
    Ann Hum Biol; 2018 Feb; 45(1):66-71. PubMed ID: 28971704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients.
    Ruaño G; Villagra D; Szarek B; Windemuth A; Kocherla M; Gorowski K; Berrezueta C; Schwartz HI; Goethe J
    Biomark Med; 2011 Aug; 5(4):439-49. PubMed ID: 21861666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes.
    Villagra D; Goethe J; Schwartz HI; Szarek B; Kocherla M; Gorowski K; Windemuth A; Ruaño G
    Biomark Med; 2011 Aug; 5(4):427-38. PubMed ID: 21861665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.
    Serrano D; Lazzeroni M; Zambon CF; Macis D; Maisonneuve P; Johansson H; Guerrieri-Gonzaga A; Plebani M; Basso D; Gjerde J; Mellgren G; Rotmensz N; Decensi A; Bonanni B
    Pharmacogenomics J; 2011 Apr; 11(2):100-7. PubMed ID: 20309015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.